SCHEMBL9068182

SCHEMBL9068182

CCC1[C]c2ccccc21

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR5A P47898 1/20 0.31
HTR2A P28223 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10474594 0.69
SCHEMBL6355081 0.65 HTR2A (0.32) HTR2A
SCHEMBL217130 0.65 HTR2A (0.31) HTR2A
SCHEMBL29366966 0.64 HTR2A (0.40) HTR5AHTR2A
SCHEMBL6351667 0.64 NPC1 (0.31) HTR5A
SCHEMBL4607718 0.64
SCHEMBL6345273 0.64 ACHE (0.34) HTR2A
SCHEMBL6343799 0.63
SCHEMBL6355108 0.63 ACHE (0.33) HTR2A
SCHEMBL455641 0.61 HTR2A (0.34) HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150291728-A1 EPOXY COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE EPOXY RESIN COMPOSITION DAICEL CORPORATION (JP) 2015-10-15 US disclosed
EP-2921513-A1 EPOXY COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE EPOXY RESIN COMPOSITION Daicel Corporation (JP) 2015-09-23 EP disclosed
US-5502207-A ALKENYL-SUBSTITUTED BISNADIMIDE MARUZEN PETROCHEMICAL CO., LTD. (JP) 1996-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150291728-A1 EPOXY COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE EPOXY RESIN COMPOSITION CBR1, SEM1, EEF1A1 HTR5A 2653/4885HTR2A 3268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.